PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Arthritis & Rheumatism

• Publication date

  2005-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.20958PMID 15751068
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Longterm Efficacy of Interferon- α for Extrahepatic Disease Associated with Hepatitis C Virus Infection

  2004cited by this paper
• Efficacy and safety of rituximab in type II mixed cryoglobulinemia.

  2003cited by this paper
• Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20.

  2003cited by this paper
• Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection

  2003cited by this paper
• Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

  2002cited by this paper
• Natural Interferon-a Versus Its Combination With 6-MethylPrednisolone in the Therapy of Type I 1 Mixed Cryoglobulinemia : A Long-Term , Randomized , Controlled Study

  2002cited by this paper
• Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.

  2002cited by this paper
• Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha.

  2000influential reference
• Pegylated interferon‐α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data

  2000cited by this paper
• Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group.

  2000cited by this paper
• Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma.

  2000cited by this paper
• Extrahepatic manifestations of chronic hepatitis C

  1999cited by this paper
• Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.

  1999cited by this paper
• [Extrahepatic manifestations of chronic hepatitis C].

  1998cited by this paper
• Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection.

  1997cited by this paper
• Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.

  1994cited by this paper
• Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C

  1994cited by this paper
• Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study.

  1994cited by this paper
• Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial.

  1993cited by this paper
• A role for hepatitis C virus infection in type II cryoglobulinemia.

  1992cited by this paper

• Post-Treatment Occurrence of Serum Cryoglobulinemia in Chronic Hepatitis C Patients

  2024cites this paper
• Severe Cryoglobulinemic Vasculitis After Cytoreductive Therapy In Waldenström´S Macroglobulinemia And Hepatitis C-Virus: A Case Report

  2022cites this paper
• Persistent cryoglobulinemia after antiviral treatment is associated with advanced fibrosis in chronic hepatitis C patients

  2022cites this paper
• Rheumatologic manifestations of hepatitis C in the era of direct-acting antiviral agents.

  2020cites this paper
• Principales vasculitis necrosantes

  2020cites this paper
• Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.

  2020cites this paper
• Peripheral Neuropathies in Infectious Diseases

  2019cites this paper
• Rheumatologic manifestations of hepatic diseases

  2019cites this paper
• Frequency of Dermatological Disorders Associated with Hepatitis C Virus Infection in Sharkia Governorate, Egypt

  2019cites this paper
• Principales vascularites nécrosantes

  2019cites this paper
• Hepatitis C-related cryoglobulinemic neuropathy: potential role of oxcarbazepine for pain control

  2018cites this paper
• Cryoglobulinémies

  2018cites this paper
• Chapter 12 HCV , Mixed Cryoglobulinemia and Malignant

  2018cites this paper
• Targeting cellular nuclear export to inhibit influenza A virus replication

  2018cites this paper
• Autoimmune Kidney Diseases Associated with Chronic Viral Infections.

  2018cites this paper
• Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis

  2018cites this paper
• Editorial: interferon‐free DAAs are a great boon for patients with hepatitis C and cryoglobulinaemia

  2018cites this paper
• Multicentre study of hepatitis C virus status in Egyptian patients with B-cell non-Hodgkin’s lymphoma with assessment of patients’ immunological state

  2017cites this paper
• HCV , Mixed Cryoglobulinemia and Malignant

  2017cites this paper
• Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study.

  2017cites this paper
• Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience

  2017cites this paper
• International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement.

  2017cites this paper
• Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?

  2017influential citation
• Extrahepatic Replication of HCV

  2016cites this paper
• Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody.

  2016cites this paper
• Management of Vasculitic Glomerulonephritis

  2016cites this paper
• Efficacy and safety of combined pegylated interferon/ribavirin therapy in the management of rheumatological manifestations of chronic HCV patients

  2016cites this paper
• ISSN 2320-5407 International Journal of Advanced Research (2016), Volume 4, Issue 4, 573-586

  2016cites this paper
• Current Treatment of Cryoglobulinemic Vasculitis

  2016cites this paper
• Cryoglobulins and Cryoglobulinemia

  2016cites this paper
• Long‐term effect of HCV eradication in patients with mixed cryoglobulinemia: A prospective, controlled, open‐label, cohort study

  2015cites this paper
• Extrahepatic morbidity and mortality of chronic hepatitis C.

  2015cites this paper
• [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].

  2015cites this paper
• [Treatment of cryoglobulinemic vasculitis associated with hepatitis C virus infection].

  2015cites this paper
• Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.

  2015cites this paper
• [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].

  2015cites this paper
• TYPE II MIXED CRYOGLOBULINEMIA IN PATIENTS WITH HEPATITIS C VIRUS: TREATMENT WITH PEGYLATED-INTERFERON AND RIBAVIRIN

  2015cites this paper
• Treatment of cryoglobulinemic vasculitis associated with hepatitis C virus infection

  2015cites this paper
• Biologic therapy in ANCA-negative vasculitis.

  2015cites this paper
• Treatment for hepatitis C virus‐associated cryoglobulinaemic vasculitis

  2014cites this paper
• Resolution of neurological deficits secondary to spontaneous intracranial haemorrhage and posterior reversible encephalopathy syndrome (PRES) in a patient with hepatitis C-associated cryoglobulinaemia: a role for plasmapheresis

  2014cites this paper
• Diagnostics and Treatment of Cryoglobulinaemia: It Takes Two to Tango

  2014cites this paper
• Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.

  2014cites this paper
• Membranoproliferative Glomerulonephritis, Type II Cryoglobulinemia and Triple Therapy for Hepatitis C: A Case Series and Review of the Literature

  2014cites this paper
• Chapter 66 – Immunotherapy

  2014cites this paper
• Glomerular Diseases as Extrahepatic Manifestations of Hepatitis C Virus Infection

  2014cites this paper
• Interleukin 28B Gene Polymorphisms in Hepatitis C Virus-related Cryoglobulinemic Vasculitis

  2014cites this paper
• Evaluation of the liver condition in chronic hepatitis C virus patients with and without vasculitis

  2014cites this paper
• HCV, Mixed Cryoglobulinemia and Malignant Lymphoproliferation

  2013cites this paper
• Ю.Ю. Рябоконь, О.П. Машко, А.В. Абрамов, Д.П. Іпатова СУЧАСНІ ПІДХОДИ ДО ЛІКУВАННЯ ХВОРИХ НА ХРОНІЧНИЙ ГЕПАТИТ С З НАЯВНІСТЮ ПОЗАПЕЧІНКОВИХ ПРОЯВІВ

  2013cites this paper
• Therapy for hepatitis C virus-related cryoglobulinemic vasculitis.

  2013cites this paper
• Life-Threatening Cryoglobulinemic Patients With Hepatitis C

  2013cites this paper
• Principales vascularites nécrosantes

  2013cites this paper
• Treatment of ANCA-Negative Small Vessel Vasculitis

  2013cites this paper
• Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis.

  2013cites this paper
• The Place of Immunotherapy in the Management of HCV-Induced Vasculitis: An Update

  2012cites this paper
• [Current possibilities for treatment for hepatitis C virus-induced cryoglobulinemic vasculitis and B-cell lymphoma].

  2012cites this paper
• Immune-Related Disorders and Extrahepatic Diseases in Chronic HCV Infection

  2012cites this paper
• Hepatitis C Virus Infection and Mixed Cryoglobulinemia

  2012cites this paper
• Autoimmune manifestations in viral hepatitis

  2012cites this paper
• Central nervous system vasculitis and polyneuropathy as first manifestations of hepatitis C.

  2012cites this paper
• Management of rheumatic disease with comorbid HBV or HCV infection

  2012cites this paper
• A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.

  2012cites this paper
• The cryoglobulinaemias.

  2012cites this paper
• Chapter 9: Infection-related glomerulonephritis

  2012cites this paper
• Vasculitic multiplex mononeuritis: polyarteritis nodosa versus cryoglobulinemic vasculitis

  2012cites this paper
• Clinical and Immunological Features of HCV/HIV Co-infected Patients with Mixed Cryoglobulinemia

  2012cites this paper
• PIRR Therapy in HCV-Related Mixed Cryoglobulinemia

  2012cites this paper
• Cryoglobulinemia in HCV-Positive Renal Transplant and Liver Transplant Patients

  2012cites this paper
• Should HCV-Positive Asymptomatic Patients with Mixed Cryoglobulinemia Be Treated with Combined Antiviral Therapy?

  2012cites this paper
• Extrahepatic Manifestations of Chronic HCV

  2012cites this paper
• Cutaneous Cryoglobulinemic Vasculitis

  2012cites this paper
• Long-Term Course of Patients with Mixed Cryoglobulinemia

  2012cites this paper
• Kutane leukozytoklastische Vaskulitis, Purpura Schönlein-Henoch und kryoglobulinämische Vaskulitis

  2012cites this paper
• SUCCESSFUL RITUXIMAB THERAPY OF HCV-CRYOGLOBULINEMIC VASCULITIS WITH SEVERE ULCERATIVE AND NECROTIC LESIONS OF THE SKIN

  2012cites this paper
• HCV infection and cryoglobulinemia

  2012cites this paper
• Cryoglobulinemia (review).

  2012cites this paper
• KDIGO Clinical Practice Guideline for Glomerulonephritis

  2012cites this paper
• Chapitre 11 – Vascularites Systémiques

  2011cites this paper
• Hepatitis C Related Vasculitides

  2011cites this paper
• Treatment of Hepatitis C-Mediated Glomerular Disease

  2011cites this paper
• Recomendaciones de la Sociedad Española de Nefrología para el manejo de las alteraciones del metabolismo óseo-mineral en los pacientes con enfermedad renal crónica (S.E.N.-MM)

  2011cites this paper
• The association of cryoglobulinaemia with sustained virological response in patients with chronic hepatitis C

  2011cites this paper
• Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.

  2011cites this paper
• An approach to the patient with retiform purpura

  2011cites this paper
• [Current therapeutic strategies for HCV-associated cryoglobulinemia].

  2011cites this paper
• Neuromuscular Diseases Associated With Chronic Hepatitis C Virus Infection

  2011cites this paper
• A retrospective analysis of treatment outcomes in patients with hepatitis C related systemic vasculitis receiving intravenous methylprednisolone and cyclophosphamide

  2011cites this paper
• ise au point anifestations hépatiques des maladies systémiques iver involvement in systemic diseases

  2011cites this paper
• [Liver involvement in systemic diseases].

  2011cites this paper
• Interferon therapy in rheumatic diseases: state-of-the-art 2010

  2010cites this paper
• Clinical trials on systemic necrotizing vasculitides.

  2010cites this paper
• Chronic Viral Hepatitis

  2010cites this paper
• Hepatitis C Virus as a Multifaceted Disease: A Simple and Updated Approach for Extrahepatic Manifestations of Hepatitis C Virus Infection

  2010cites this paper
• Manifestations extrahépatiques au cours de l'infection par le virus de l'hépatite C

  2010cites this paper
• Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.

  2010cites this paper
• Rituximab plus Peg-interferon- (cid:1) /ribavirin compared with Peg-interferon-(cid:1) /ribavirin in hepatitis C–related mixed cryoglobulinemia Treatment of hepatitis C (HCV)–mixed

  2010cites this paper
• Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.

  2010cites this paper
• Clinical Aspects of Hepatitis C Virus Infection

  2009cites this paper
• Hepatitis C-associated rheumatic disorders.

  2009cites this paper